NASDAQ:CME

CME Group Stock Forecast, Price & News

$207.58
+3.53 (+1.73 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$205.16
Now: $207.58
$208.54
50-Day Range
$199.35
MA: $206.14
$214.04
52-Week Range
$146.89
Now: $207.58
$216.75
Volume1.27 million shs
Average Volume1.77 million shs
Market Capitalization$74.52 billion
P/E Ratio34.60
Dividend Yield1.74%
Beta0.46
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.A. to develop risk management products for Brazilian domestic and international market participants. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
CME Group logo

Industry, Sector and Symbol

Industry Security & commodity brokers, dealers, exchanges & services
Sub-IndustrySpecialized Finance
SectorFinance
Current SymbolNASDAQ:CME
CUSIP12572Q10
Phone312-930-1000
Employees4,370
Year Founded1848

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.87 billion
Cash Flow$8.80 per share
Book Value$73.18 per share

Profitability

Net Income$2.12 billion

Miscellaneous

Market Cap$74.52 billion
Next Earnings Date4/28/2021 (Confirmed)
OptionableOptionable

Headlines

CME Group Stock Is Estimated To Be Fairly Valued
April 4, 2021 |  finance.yahoo.com
CME to Launch Affordable Micro Bitcoin Futures Contract
March 31, 2021 |  finance.yahoo.com
CME Group (NASDAQ:CME) Raised to Buy at Bank of America
March 30, 2021 |  americanbankingnews.com
CME Group to Launch Micro Bitcoin Futures on May 3
March 30, 2021 |  finance.yahoo.com
IS CME Stock A Buy or Sell?
March 23, 2021 |  finance.yahoo.com
When Cme Group $CME Moves Investors should Listen
March 6, 2021 |  marketwatch.com
See More Headlines

MarketRank

Overall MarketRank

1.74 out of 5 stars

Finance Sector

386th out of 1,955 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

5th out of 19 stocks

Analyst Opinion: 2.1Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$207.58
+3.53 (+1.73 %)
(As of 04/16/2021 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CME Group (NASDAQ:CME) Frequently Asked Questions

Is CME Group a buy right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group
or view top-rated stocks.

What stocks does MarketBeat like better than CME Group?

Wall Street analysts have given CME Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CME Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for CME Group
.

How can I listen to CME Group's earnings call?

CME Group will be holding an earnings conference call on Wednesday, April 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) issued its quarterly earnings data on Tuesday, February, 9th. The financial services provider reported $1.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.36 by $0.03. The financial services provider earned $1.10 billion during the quarter, compared to the consensus estimate of $1.10 billion. CME Group had a trailing twelve-month return on equity of 9.22% and a net margin of 43.68%. The business's quarterly revenue was down 3.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.52 earnings per share.
View CME Group's earnings history
.

How has CME Group's stock been impacted by Coronavirus?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CME stock has increased by 6.6% and is now trading at $207.58.
View which stocks have been most impacted by COVID-19
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Thursday, February 4th. Investors of record on Wednesday, March 10th will be given a dividend of $0.90 per share on Thursday, March 25th. This represents a $3.60 annualized dividend and a dividend yield of 1.73%. The ex-dividend date is Tuesday, March 9th. This is a boost from CME Group's previous quarterly dividend of $0.85.
View CME Group's dividend history
.

Is CME Group a good dividend stock?

CME Group pays an annual dividend of $3.60 per share and currently has a dividend yield of 1.74%. CME Group does not yet have a strock track record of dividend growth. The dividend payout ratio of CME Group is 52.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 54.46% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

What price target have analysts set for CME?

15 brokerages have issued 12-month price objectives for CME Group's stock. Their forecasts range from $135.00 to $230.00. On average, they anticipate CME Group's stock price to reach $193.67 in the next twelve months. This suggests that the stock has a possible downside of 6.7%.
View analysts' price targets for CME Group
or view top-rated stocks among Wall Street analysts.

Who are CME Group's key executives?

CME Group's management team includes the following people:
  • Mr. Terrence A. Duffy, Chairman & CEO (Age 63, Pay $5.28M)
  • Mr. John William Pietrowicz M.B.A., CPA, Chief Financial Officer (Age 57, Pay $1.41M)
  • Ms. Julie Holzrichter, Sr. MD & COO (Age 52, Pay $1.26M)
  • Mr. Kevin Kometer, Sr. MD & Chief Information Officer (Age 56, Pay $1.16M)
  • Mr. Jack Tobin, MD & Chief Accounting Officer (Age 57)
  • Mr. John C. Peschier, Managing Director of Investor Relations (Age 53)
  • Ms. Kathleen M. Cronin, Sr. MD, Gen. Counsel & Corp. Sec. (Age 58)
  • Ms. Anita Liskey, Sr. Managing Director of Corp. Marketing & Communications (Age 56)
  • Ms. Hilda Harris Piell, Sr. MD & Chief HR Officer (Age 53)
  • Ms. Eileen Beth Keeve, Managing Director of Organizational Devel. (Age 67)

What is Terry Duffy's approval rating as CME Group's CEO?

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

Who are some of CME Group's key competitors?

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), The Walt Disney (DIS), Visa (V), Netflix (NFLX), The Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Hamlin Capital Management LLC (0.12%), Royal London Asset Management Ltd. (0.07%), Retirement Systems of Alabama (0.04%), State of Alaska Department of Revenue (0.03%), NatWest Group plc (0.03%) and Windward Capital Management Co. CA (0.02%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group
.

Which institutional investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including UMB Bank N A MO, Fulcrum Capital LLC, Retirement Systems of Alabama, Royal London Asset Management Ltd., State of Alaska Department of Revenue, Clear Street Markets LLC, First Midwest Bank Trust Division, and Pacer Advisors Inc.. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Hilda Harris Piell, John W Pietrowicz, Julie Winkler, Ken Vroman, Kevin Kometer, Martin J Gepsman, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group
or view top insider-selling stocks.

Which institutional investors are buying CME Group stock?

CME stock was purchased by a variety of institutional investors in the last quarter, including Clarus Group Inc., Hamlin Capital Management LLC, Gofen & Glossberg LLC IL, Oak Harvest Investment Services, NatWest Group plc, Everence Capital Management Inc., Park National Corp OH, and NuWave Investment Management LLC.
View insider buying and selling activity for CME Group
or or view top insider-buying stocks.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $207.58.

How much money does CME Group make?

CME Group has a market capitalization of $74.52 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis.

How many employees does CME Group have?

CME Group employs 4,370 workers across the globe.

When was CME Group founded?

CME Group was founded in 1848.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

Where are CME Group's headquarters?

CME Group is headquartered at 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.